Yc. Wang et al., p53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis, CLIN CANC R, 5(1), 1999, pp. 129-134
An association between the BstUI (Pro/Pro) genotype of the p53 codon 72 pol
ymorphism and lung cancer has been reported previously (X. Jin et al,, Carc
inogenesis (Lond,), 16: 2205-2208, 1995), However, the genotype distributio
n of p53 codon 72 polymorphism as well as the association of this polymorph
ism with lung cancer risk and prognosis remain undefined in the Taiwanese p
opulation. Therefore, me investigated the genotype distribution of p53 codo
n 72 polymorphism in 194 lung cancer patients and 152 noncancer controls. T
he genotype frequencies in Taiwanese noncancer controls were 0.56 (Arg) and
0.44 (Pro), chi(2) analysis indicated significant differences in genotype
distribution of p53 from other reports in Swedish (P < 0.001), Spanish (P <
0.001), Caucasians in the United States (P = 0.002), and African-Americans
(P = 0.027), In addition, our data suggest that the Pro allele of the p53
codon 72 polymorphism increased the risk of lung cancer among female Taiwan
ese. The female patients with genotype Pro/Pro showed a significantly incre
ased odds ratio (3.14; confidence interval, 1.48-6.64; P = 0.003) of having
lung adenocarcinoma, compared with normal controls with the other genotype
s, Patients with the Pro/Pro genotype had an odds ratio of 2.63 (confidence
interval, 1.22-5.68; P = 0.01) higher than those with the other genotypes
to be diagnosed with lung cancer at the early ages, We further investigated
the association of p53 codon 72 polymorphism with prognosis in 133 lung ca
ncer patients. Patients with the Pro/Pro genotype tended to have poorer pro
gnosis than those with the Arg/Pro genotype (P 0.05, by the log-rank test).
Our data suggested that p53 codon 72 polymorphism may play a role in cance
r susceptibility and prognosis in specific classes of lung cancer patients
in Taiwan.